Study of Zanubrutinib in Japanese Participants With B-Cell Malignancies
Clinical trial NCT04172246 · COMPLETED
Trial details
- NCT number
- NCT04172246
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-29
- Primary completion
- 2023-05-10
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.